Qurient Co. Ltd.

Qurient Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW1777
Market Cap
KRW193.93 B
Shares Outstanding
7.68 M
Public Float
6.27 M

Profile

Address
8/F, Tower C, PDCC Building
Seongnam GY 13487
Korea, Republic Of
Employees -
Website http://www.qurient.com
Updated 09/14/2018
Qurient Co., Ltd. engages in the development of novel therapeutics. Its research and development pipeline includes tuberculosis, atopic dermatitis, asthma and cancer. It offers drug development management and business development services.

Financials

View All
Created with Highcharts 5.0.14Qurient Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Thousands.4 820 3004 820 30010 706 19710 706 1979 301 9779 301 97710 535 97710 535 97712 196 20012 196 2002013201420152016201702.5M5M7.5M10M12.5M15M
Created with Highcharts 5.0.14Qurient Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Thousands.00215 280215 28000000020132014201520162017050k100k150k200k250k

Wang-Shik Ryu
Non-Executive Director
Ki-Yean Nam
Chief Executive Officer & Director